29 July 2024
Revolution Beauty Group plc
("Revolution Beauty", the "Group", or the "Company")
BLOCK LISTING SIX MONTHLY RETURN
Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, today makes the following notification pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies regarding its existing block listing announced on 26 January 2024, effective 29 January 2024.
The Company has now allotted 689,172 shares under its existing block admission of 10,000,000 shares announced on 26 January 2024, effective 29 January 2024, in respect of the Company's Long Term Incentive Plan.
|
Name of applicant: |
Revolution Beauty Group plc |
|||
|
Name of scheme: |
Revolution Beauty Long Term Incentive Plan |
|||
|
Period of return: |
From: |
29 January 2024 |
To: |
28 July 2024 |
|
Balance of unallotted securities under scheme(s) from previous return: |
10,000,000 Ordinary Shares of 1p |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
689,172 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
9,310,828 |
|||
|
Name of contact: |
Neil Catto - Chief Financial Officer |
|||
|
Telephone number of contact: |
+44 (0) 2023 100 2222 |
|||
|
|
|
|
|
|
For further information, please contact:
Investor Relations
Lauren Brindley, CEO
Neil Catto, CFO
Investor.Relations@revolutionbeautyplc.com
Joint Corporate Brokers
Panmure Liberum (NOMAD): Edward Thomas / Dru Danford / John More
Tel: +44 (0) 203 100 2222
Zeus: Nick Cowles / Jamie Peel / Jordan Warburton
Tel: +44 (0) 161 831 1512
Media enquiries
Headland Consultancy: Matt Denham / Antonia Pollock
Tel: +44 (0)20 3805 4822
Revolutionbeauty@headlandconsultancy.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
